ArticleBiomedicines2024

Obinutuzumab in Combination with Alternative Chlorambucil Schedules in Front-Line Treatment of Chronic Lymphocytic Leukemia: A Study by KroHem, the Croatian Cooperative Group for Hematologic Diseases.

Igor Aurer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.